Delivery Order SPE2DB20D3103-SPE2DB23FN4H8
Award Date
5/17/23
Potential Completion Date
5/18/23
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,982,789 units of the medication Capecitabine 500 mg tablets. The contract has a ceiling value of $1,938.09 and a period of performance through March 18, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Capecitabine 500 mg tablets. The contract has a ceiling value of $6,330.32 and an ultimate completion date of October 19, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Capecitabine 500 mg tablets to the Defense Logistics Agency (DLA). The $12,351.20 firm-fixed-price delivery order, awarded on January 30, 2024, has an ultimate completion date of January 31, 2024. The contract is not designated as a set-aside award. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,872.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order (SPE2DB20D3103|SPE2DB25FN2H3), is for the supply of Capecitabine 500 mg tablets, a medication used in the treatment of various types of cancer. The contract has an ultimate completion date of March 28, 2025 and is structured as a firm fixed-price arrangement....
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4563298237 - CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product. The $3,091.60 firm fixed-price contract has an ultimate completion date of January 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
This federal contract award is for the pharmaceutical product Capecitabine 500 mg Tablet, which was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,927.38, is a Delivery Order type contract with a Firm Fixed Price pricing structure. The ultimate completion date is January 14, 2025, and the award was made on January 13, 2025. The contract was awarded by the Defense Logistics...
This federal contract award, with ID SPE2DX15D1022|SPE2DX21F5XAX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $91,699.56 firm fixed-price delivery order is for the pharmaceutical product Ibrance 100 mg capsules. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $7,484.74 and an ultimate completion date of December 29, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products. The contract, valued at $1,476.00, is a Firm Fixed Price Delivery Order with a completion date of May 7, 2024. It covers the delivery of Acarbose 100 mg tablets in 90-count packages. The contract was awarded on May 6, 2024 and does not have a set-aside designation, indicating it was awarded...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,358.99 firm fixed-price delivery order is for the pharmaceutical product XTAMPZA ER 27 MG CAPSULE 100S. The contract has a completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...